Cita APA

Decker, B., Allen, J., Luccarini, C., Pooley, K. A., Shah, M., Bolla, M. K., . . . Easton, D. F. (2017). Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks. J Med Genet.

Citación estilo Chicago

Decker, Brennan, et al. "Rare, Protein-truncating Variants in ATM, CHEK2 and PALB2, but Not XRCC2, Are Associated With Increased Breast Cancer Risks." J Med Genet 2017.

Cita MLA

Decker, Brennan, et al. "Rare, Protein-truncating Variants in ATM, CHEK2 and PALB2, but Not XRCC2, Are Associated With Increased Breast Cancer Risks." J Med Genet 2017.